EMERGENCE OF OXA-48-LIKE CARBAPENEMASES IN CLINICAL ENTEROBACTERALES FROM GUATEMALA

Simple item page
dc.contributor.authorCarmen J. Mazariegos
dc.contributor.authorAnna Quinto
dc.contributor.authorAndres Herrera
dc.contributor.authorSara E. Barillas
dc.contributor.authorLaura R. Valenzuela
dc.contributor.authorGabriela Ordóñez
dc.contributor.authorPaola Sierra
dc.contributor.authorCarolina Arévalo
dc.contributor.authorChristine Seah
dc.contributor.authorRoberto G. Melano
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:49:33Z
dc.date.available2026-03-22T20:49:33Z
dc.date.issued2024
dc.description.abstractABSTRACT Five isolates (four Klebsiella pneumoniae and one Escherichia coli ) displaying resistance to piperacillin/tazobactam and ertapenem and reduced susceptibility to imipenem were found positive for bla OXA-48 -like genes ( bla OXA-181 and bla OXA-232 ) carried on plasmids described previously. Although two K. pneumoniae recovered in 2020 were clonally related, the results suggest that bla OXA-48 -like genes have been circulating in Guatemala since 2019. This is the first report of this type of carbapenemase in Central America.
dc.identifier.doi10.1101/2024.04.04.588149
dc.identifier.urihttps://doi.org/10.1101/2024.04.04.588149
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/84292
dc.language.isoen
dc.sourceInstituto Nacional de Salud
dc.subjectErtapenem
dc.subjectKlebsiella pneumoniae
dc.subjectImipenem
dc.subjectMicrobiology
dc.subjectBiology
dc.subjectPlasmid
dc.subjectPiperacillin
dc.subjectEscherichia coli
dc.subjectPiperacillin/tazobactam
dc.subjectGene
dc.titleEMERGENCE OF OXA-48-LIKE CARBAPENEMASES IN CLINICAL ENTEROBACTERALES FROM GUATEMALA
dc.typepreprint

Files

Collections

Artículo Científico (Preprint)